_256_384.jpg)
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
SPARC to receive 55% equity in Tiller Therapeutics
Subscribe To Our Newsletter & Stay Updated
